Pfizer Boasts Strong Oncology Portfolio: Can it Sustain Growth?
PFE's oncology portfolio, boosted by Seagen and late-stage pipeline assets, may fuel growth amid lackluster stock performance.
| Ticker |
BMY
|
| CIK | 0000014272 |
| SIC | 2834 |
| Sector | Manufacturing |
| Industry Category | Pharmaceutical Products |
| Industry Group | Pharmaceutical Preparations |
Our team will help you customize a package that meets the needs of your business.
Request a Consultation|
Standardized FinancialsdocsIntrinio provides professional-grade historical financial data. This data is standardized, cleansed and verified to ensure the highest quality data sourced directly from the XBRL financial statements. The primary purpose of standardized financials are to facilitate comparability across a single company’s fundamentals and across all companies fundamentals. For example, it is possible to compare total revenues between two companies as of a certain point in time, or within a single company across multiple time periods. This is not possible using the as reported financial statements because of the inherent complexity of reporting standards. Below is a preview of several data points from each financial statement, as well as a sample of our many calculated metrics: |
|||||||||||||||||||||
|
Income Statement
|
Balance Sheet
|
||||||||||||||||||||
|
Cash Flow Statement
|
Calculations
|
||||||||||||||||||||
|
Latest NewsdocsIntrinio provides up-to-date news articles on every US company from various sources. Here are several examples: |
Pfizer Boasts Strong Oncology Portfolio: Can it Sustain Growth?PFE's oncology portfolio, boosted by Seagen and late-stage pipeline assets, may fuel growth amid lackluster stock performance. How to Maximize Your Retirement Portfolio with These Top-Ranked Dividend StocksThe traditional ways to plan for your retirement may mean income can no longer cover expenses post-employment. But what if there was another option that could provide a steady, reliable source of income in your nest egg years? Q1 Rundown: Royalty Pharma (NASDAQ:RPRX) Vs Other Branded Pharmaceuticals StocksQuarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at Royalty Pharma (NASDAQ:RPRX) and the best and worst performers in the branded pharmaceuticals industry. Bristol-Myers Squibb (NYSE:BMY) Declares US$0.62 Common and US$0.50 Preferred DividendsBristol-Myers Squibb (NYSE:BMY) recently announced dividend declarations for common and preferred stock, potentially adding some weight to the company's stock performance over the past month. The stock saw a modest gain of 1%, which aligns closely with broader market movements amid geopolitical and economic factors such as the Middle Eastern conflict and anticipation around the Federal Reserve's decision on interest rates. Additionally, updates regarding clinical trial results for product... Bristol Myers Squibb Announces DividendPRINCETON, N.J., June 17, 2025--Bristol Myers Squibb Announces Dividend |